Healthcare products and solutions provider Henry Schein has unveiled robust financial results for the fourth quarter, signaling continued momentum across its diversified business portfolio. The company disclosed that net earnings climbed to $101 million, translating to $0.85 per share, compared to $94 million or $0.74 per share in the prior-year period. On an adjusted basis excluding one-time items, Schein’s earnings reached $160 million, or $1.34 per share, up from $149 million or $1.19 per share year-over-year.
Revenue growth accelerated in the quarter, advancing to $3.43 billion from $3.191 billion previously, representing a solid expansion in top-line performance. CEO Stanley M. Bergman highlighted the consistent strength across Henry Schein’s operational segments, noting that “Our global equipment, specialty products, and technology divisions have been particularly strong contributors. This performance enabled us to exceed the enhanced financial guidance we shared during our third-quarter earnings announcement.”
Earnings Growth Propelled by Diversified Revenue Streams
The earnings surge reflects robust execution across multiple business lines. The equipment segment, specialty products division, and technology services platform all demonstrated accelerating demand, collectively driving the quarter’s outperformance relative to management expectations. This diversified growth pattern provides a buffer against sector concentration risk and underscores the resilience of Schein’s operational model.
Looking ahead to the full year 2026, Henry Schein has established ambitious yet achievable targets. The company projects non-GAAP diluted earnings per share in the range of $5.23 to $5.37, while anticipating total sales growth of approximately 3% to 5% for the fiscal year, which would position annual revenues around $13.2 billion. This guidance reflects management’s confidence in sustained market demand and operational execution across its global footprint.
Market participants responded positively to Schein’s announcement, with HSIC shares closing at $80.57 on the Nasdaq, representing a 1.26% gain during the session. The stock’s performance reflects investor appreciation for both the company’s historical results and its forward-looking outlook.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Henry Schein Reports Strong Q4 Performance, Sets Bullish 2026 Targets
Healthcare products and solutions provider Henry Schein has unveiled robust financial results for the fourth quarter, signaling continued momentum across its diversified business portfolio. The company disclosed that net earnings climbed to $101 million, translating to $0.85 per share, compared to $94 million or $0.74 per share in the prior-year period. On an adjusted basis excluding one-time items, Schein’s earnings reached $160 million, or $1.34 per share, up from $149 million or $1.19 per share year-over-year.
Revenue growth accelerated in the quarter, advancing to $3.43 billion from $3.191 billion previously, representing a solid expansion in top-line performance. CEO Stanley M. Bergman highlighted the consistent strength across Henry Schein’s operational segments, noting that “Our global equipment, specialty products, and technology divisions have been particularly strong contributors. This performance enabled us to exceed the enhanced financial guidance we shared during our third-quarter earnings announcement.”
Earnings Growth Propelled by Diversified Revenue Streams
The earnings surge reflects robust execution across multiple business lines. The equipment segment, specialty products division, and technology services platform all demonstrated accelerating demand, collectively driving the quarter’s outperformance relative to management expectations. This diversified growth pattern provides a buffer against sector concentration risk and underscores the resilience of Schein’s operational model.
Forward-Looking Guidance Supports Investor Confidence
Looking ahead to the full year 2026, Henry Schein has established ambitious yet achievable targets. The company projects non-GAAP diluted earnings per share in the range of $5.23 to $5.37, while anticipating total sales growth of approximately 3% to 5% for the fiscal year, which would position annual revenues around $13.2 billion. This guidance reflects management’s confidence in sustained market demand and operational execution across its global footprint.
Market participants responded positively to Schein’s announcement, with HSIC shares closing at $80.57 on the Nasdaq, representing a 1.26% gain during the session. The stock’s performance reflects investor appreciation for both the company’s historical results and its forward-looking outlook.